Healthcare EDI Market to Hit USD 7.11 Billion by 2029 with 9.7% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Oct. 15, 2024 /PRNewswire/ — The global healthcare EDI market is projected to reach USD 7.11 billion by 2029 from USD 4.47 billion in 2024, with a CAGR of 9.7%. Key drivers include increased claims submissions, growing use of API integrations, and regulatory mandates. Adoption of RESTful APIs, File Transfer Protocols (FTPs), and advancements in automated error detection contribute to growth. The shift to value-based care models, cloud storage, and AI-driven analytics further drive demand for EDI solutions in enhancing revenue cycle management and patient care outcomes.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=130571438

Browse in-depth TOC on “Healthcare EDI Market

200 – Tables

50 – Figures

250 – Pages

The rising shift towards the use of automated data validation with artificial intelligence (AI), cloud-based EDI solutions, the expansion of API-based plug-ins, and the increased adoption of blockchain technology to enhance security are expected to bolster the growth of the healthcare EDI market. Moreover, to promote health data interoperability, the 2020 Cures Act Final Rule from ONC enforced important 21st Century Cures Act provisions, such as the ban on information blocking, which is expected to provide growth opportunities for vendors offering healthcare EDI market. The cloud-based EDI solutions are gaining popularity due to their cost-effectiveness, flexibility, scalability, and improved security over traditional on-premises EDI solutions. In addition, real-time data exchange, reduced IT hassle, integration, and quick deployment are some other factors contributing to cloud-based EDI solutions’ highest growth.

By transaction type, the claims management software segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to an increased volume of healthcare claims, the intricacy of healthcare billing and regulatory requirements, and the need for a decrease in errors and claim denials.

The software segment is expected to hold a significant share of the healthcare EDI market by component. Healthcare providers and payers can automate their workflows by decreasing administrative costs, reducing errors, and enhancing data security with the effective utilization of healthcare EDI software. The seamless integration of software, real-time data exchange, and automation in healthcare transactions are some of the major factors driving market growth.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=130571438

Key players in the healthcare EDI market are McKESSON CORPORATION (US), UnitedHealth Group Incorporated (US), Cognizant (US), IBM (US), Veradigm LLC (US), athenahealth (US), Axway (US), Boomi (US), and True Commerce, Inc. (US) among others.

These market players have offered a diverse range of products and services and have operations worldwide. They rely on technological advancements to avail themselves of innovative products and services and increase their global footprint. These players focus on acquisitions, collaborations, agreements, mergers, product launches & updates, partnerships, expansions, and other recent developments to expand their global reach and develop advanced EDI solutions. 

McKESSON CORPORATION:

McKesson CORPORATION provides software and services used in pharmacy services, specialty practices, biopharma, pharmaceutical distribution, and medical supplies and equipment. The company has a strong foothold in the US, from where it generated more than 90% share of its revenue. The company provides claims management and supply management software and services. It adopted acquisitions and product approvals as critical strategies to increase its revenue. The company’s supply management offerings provide data exchange tools that streamline pharmacy operations by managing product data for pricing updates, purchase orders, invoicing, and customization for specific customer needs. Their claims management solution offers claims processing and supports various plan types like Medicaid, Medicare, FIDA, dual-eligibility services, and automated electronic payments.

UnitedHealth Group Incorporated:

UnitedHealth Group is a healthcare company that offers healthcare products and insurance services. The company caters to a broad range of healthcare providers, such as hospitals, doctors, pharmacies, health plan organizations, and life science companies. Through Optum, the company provides integrated claims management software designed explicitly for eligibility and referrals, prior authorization, claims status, and reconsideration. The company has created a significant footprint in the healthcare services industry through investments in digital health innovations and collaborations with healthcare providers.

Cognizant

Cognizant has a strong geographical footprint across North America and Europe, from where it generated more than 90% share of its revenue. Cognizant offers claims management software that simplifies the process of handling EDI for healthcare payers. With EDI consolidation functionality, it consolidates all interactions into one efficient system instead of managing multiple connections.

For more information, Inquire Now!

Related Reports:

Healthcare Analytics Market

Healthcare BPO Market

Healthcare Cloud Computing Market

Home Healthcare Market

Healthcare Simulation Market

Get access to the latest updates on Healthcare EDI Companies and Healthcare EDI Market Share

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://healthtechnologynet.com/wp-content/uploads/2024/10/MarketsandMarkets-2.jpg

View original content:https://www.prnewswire.com/news-releases/healthcare-edi-market-to-hit-usd-7-11-billion-by-2029-with-9-7-cagr–marketsandmarkets-302276018.html

SOURCE MarketsandMarkets

Staff

Recent Posts

BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 16, 2024) - BioHarvest Sciences Inc. (CSE:…

29 mins ago

Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT’s 2024 Advancing Gene and Cell Therapies for Cancer Conference

PH-894: Potent and Specific Silencing of BRD4 in NK CellsMarlborough, Massachusetts--(Newsfile Corp. - October 16,…

29 mins ago

Confidential Home Detox for Drugs and Alcohol Now Serving Los Angeles

Private Nurses Providing In-Home Medical Detox Services for Chemical DependencyLOS ANGELES, CA / ACCESSWIRE /…

29 mins ago

Jaguar Health Launches FDA-Approved Oral Mucositis Prescription Product Gelclair in the U.S.

Gelclair® is the company's third commercialized prescription productOral mucositis, also called "chemo mouth," a painful…

30 mins ago